Physiomics plc announced that Peter Sargent will be stepping down from his role as Executive Director of the Company to pursue other opportunities, with effect from 29 May 2026. The Company has commenced its search to appoint a new CEO and further announcements will be made in due course. Dr Jim Millen, currently Non-Executive Chairman, has confirmed that he will be available to resume the position of Executive Chairman from the date of Dr Sargent's departure, for as long as required to ensure business continuity in the event a suitable replacement has not been found by that date.
Dr Millen was formerly the CEO of the Company from 2016 to 2024, during which time he grew the business from total income of under £300,000 to a peak of over £900,000, as well as securing a major contract with long term client Merck KGaA and kicking off the Company's personalised medicine initiative.
